
CIMZIA
(certolizumab pegol)
CIMZIA is a prescription medicine called a Tumor Necrosis Factor (TNF) blocker used to:
-
Lessen the signs and symptoms of moderately to severely active Crohn’s disease (CD) in adults who have not been helped enough by usual treatments
-
Treat moderately to severely active rheumatoid arthritis (RA) in adults
-
Treat active polyarticular juvenile idiopathic arthritis (pJIA) in patients 2 years of age and older
-
Treat active psoriatic arthritis (PsA) in adults
-
Treat active ankylosing spondylitis (AS) in adults
-
Treat active non-radiographic axial spondyloarthritis (nr-axSpA) with measures of inflammation in adults
-
Treat moderate-to-severe plaque psoriasis (PSO) in adults who may benefit from taking injections or pills (systemic therapy) or phototherapy (treatment using ultraviolet light alone or with pills)
